CINVANTI (APREPITANT) — FDA Approval NDA209296 (HERON THERAPS INC)
CINVANTI (APREPITANT) — FDA Approval NDA209296 (HERON THERAPS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CINVANTI; Active ingredients: APREPITANT; Application number: NDA209296.
| Brand name | CINVANTI |
|---|---|
| Active ingredients | APREPITANT |
| Application number | NDA209296 |
| Sponsor | HERON THERAPS INC |
| Dosage form | EMULSION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20171109 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →